1. AstraZeneca will need more than the placebo effect to placate investors [2] (Telegraph)

"AstraZeneca investors have been popping the Seroquel for a while now. But each time they looked at the share price, those psychotic feelings came wooshing back", writes Alistair Osborne.

2. Just another businessman playing the power game [3] (Financial Times)

Philip Delves Broughton defends Rupert Murdoch's actions as standard for a businessman in his position.

3. Kickstarter of the day, Flint-and-Tinder edition [4] (Reuters)

Felix Salmon points out the growing awkwardness of Kickstarter being used to provide what is essentially start-up funding.

4. All your Tumblr are belong to Them [5] (Reuters)

Paul Smalera writes on the usefulness of social media to firms which specialise in "big data".

5. Executive excess? You ain’t seen nothing yet [6] (Times)

Ian King writes that the saga of Oklahoma-based Chesapeake Energy "inspires little faith, a decade on from Enron and WorldCom, that US regulators are doing any better at keeping tabs on corporate executives."